Top Medical Device Consulting Firms: How to Choose the Right Regulatory & Quality Partner in 2026
Comprehensive guide to the leading medical device consulting firms in 2026 — covering regulatory affairs, quality systems, clinical strategy, and global market access. Includes detailed firm profiles, comparison tables, pricing insights, evaluation criteria, and a decision framework for choosing the right partner.
Why Medical Device Companies Need Consulting Partners
The medical device regulatory landscape has never been more complex. In 2026 alone, manufacturers face the FDA's Quality Management System Regulation (QMSR) transition — the most significant overhaul of US device GMP requirements in three decades — alongside the ongoing EU MDR/IVDR implementation, expanding MDSAP requirements, and rapidly evolving frameworks for AI-enabled devices, Software as a Medical Device (SaMD), and cybersecurity. For startups bringing their first product to market, mid-size companies expanding internationally, or large manufacturers navigating post-market obligations under tightening scrutiny, specialized consulting expertise is often the difference between a timely approval and months of costly delays.
Medical device consulting firms provide expertise across the full product lifecycle — from concept and regulatory strategy through design controls, submissions, clinical evidence, quality system implementation, manufacturing compliance, post-market surveillance, and global market access. The right consulting partner can accelerate your regulatory timeline, reduce the risk of FDA 483 observations or Notified Body nonconformities, and help you build quality systems that scale with your business.
But choosing the wrong partner can be equally costly: misaligned expertise, unexpected billing, or a consultant who disappears mid-submission can set your program back by months. This guide helps you navigate the landscape of medical device consulting firms, understand what differentiates them, and make an informed decision.
What Medical Device Consulting Firms Do
Core Service Areas
Medical device consulting firms typically specialize in one or more of the following areas:
| Service Area | Description | When You Need It |
|---|---|---|
| Regulatory Strategy | Device classification, pathway selection (510(k), De Novo, PMA), submission preparation, FDA correspondence | Before and during submission planning |
| Quality Systems | ISO 13485 implementation, FDA QMSR compliance, QMS design, CAPA management, management review | Pre-certification or during QMS buildout |
| Clinical Affairs | Clinical investigation planning, CER/CRA development, PMCF strategy, literature reviews, IDE applications | When clinical evidence is required |
| Design Controls | Design history file (DHF) development, design verification and validation planning, risk management (ISO 14971) | During product development |
| Global Market Access | Multi-country registration strategy, in-country representation, local regulatory submissions | International expansion |
| Auditing & Compliance | Internal audits, supplier audits, mock FDA inspections, MDSAP preparation, remediation support | Before external audits or after findings |
| Labeling & UDI | UDI implementation, labeling compliance, EUDAMED registration, eIFU strategy | Before market launch |
| Cybersecurity & SaMD | SBOM preparation, threat modeling, IEC 62443, SaMD classification, AI/ML regulatory strategy | For software-connected devices |
| Testing & Biocompatibility | ISO 10993 biological evaluation plans, sterilization validation, packaging validation, EMC testing coordination | During design verification |
| Post-Market Surveillance | PMS plans, PMCF studies, vigilance reporting, periodic safety update reports | After market launch |
Engagement Models
Consulting firms typically offer several engagement models:
- Project-based: Fixed scope and deliverables (e.g., prepare a 510(k) submission, implement ISO 13485). Best for defined needs with clear endpoints.
- Retainer / Fractional: Ongoing access to expertise on a monthly or quarterly basis. Best for startups or companies building internal capability.
- Staff augmentation: Consultants embedded in your team to fill specific gaps (e.g., interim QA manager, regulatory affairs specialist). Best for temporary resource needs.
- Turnkey programs: End-to-end service from concept to clearance/approval. Best for companies with limited internal regulatory expertise.
How to Evaluate a Medical Device Consulting Firm
Before reviewing specific firms, understand the criteria that matter most. Not every firm is right for every situation.
1. Relevant Device Experience
The most important factor is whether the firm has experience with your specific device type and classification. A firm that excels at Class I consumer wellness devices may lack the depth needed for a Class III implantable. Ask about:
- Device categories they have worked on (cardiovascular, orthopedic, IVD, SaMD, etc.)
- Regulatory pathways they have successfully navigated (510(k), De Novo, PMA, CE marking under MDR)
- Specific product codes and classification panels they are familiar with
- Case studies or references from similar projects
2. Regulatory Geography
If you are pursuing multi-market access, ensure the firm has expertise in your target regions. Some firms are US-centric; others specialize in EU MDR/IVDR or have deep presence in Asia-Pacific markets. Global firms may have local offices with in-country experts who understand the nuances of each regulatory system.
3. Team Qualifications
Evaluate the qualifications of the specific consultants who will be assigned to your project:
- RAC (Regulatory Affairs Certification) from RAPS
- Lead auditor certifications (ISO 13485, MDSAP)
- Former FDA, Notified Body, or other regulatory agency experience
- Advanced degrees in biomedical engineering, regulatory science, or related fields
- Years of industry experience and track record of successful submissions
4. Track Record and References
Ask for concrete evidence of success:
- Number of successful submissions (510(k) clearances, PMA approvals, CE certificates)
- Average time to clearance/approval for their clients
- Audit outcomes (percentage of clients passing FDA inspections or ISO audits without major nonconformities)
- Client references you can contact directly
5. Communication and Project Management
Regulatory projects are deadline-driven and detail-intensive. Evaluate:
- How they structure project timelines and milestones
- Communication cadence (weekly status calls, shared project dashboards)
- Responsiveness to questions and FDA correspondence
- Documentation practices (do they maintain organized working files you can access?)
6. Pricing Transparency
Pricing models vary widely:
| Model | Typical Range | Best For |
|---|---|---|
| Hourly rate | $150-$400/hour | Short-term, undefined-scope work |
| Fixed project fee | $15,000-$250,000+ | Defined deliverables (510(k), ISO 13485 implementation) |
| Monthly retainer | $5,000-$30,000/month | Ongoing regulatory support |
| Success-based | Base fee + bonus upon clearance | High-confidence submissions |
| Flat, all-inclusive | Single fixed price for entire registration | Multi-market projects wanting cost certainty (pioneered by Pure Global) |
Be wary of firms that cannot provide a detailed scope of work and pricing estimate. The cheapest option is rarely the best value in regulatory consulting — a failed submission or a QMS that requires complete rework costs far more than the consulting fee.
Top Medical Device Consulting Firms: Detailed Profiles
The firms below are organized into three tiers based on size, scope, and specialization. Inclusion in this list is based on publicly available information, industry reputation, service breadth, and documented track records.
Tier 1: Global Full-Service Firms
These firms offer end-to-end services across multiple regulatory jurisdictions, supported by large teams and broad capabilities.
Emergo by UL
Headquarters: Austin, Texas, USA Founded: 1997 (acquired by UL in 2019) Team Size: 400+ regulatory and quality professionals globally Offices: US, Ireland, Netherlands, UK, Germany, Japan, China, Canada, Brazil
Emergo by UL is one of the most recognized names in medical device regulatory consulting, with particular strength in global market access. As part of UL (Underwriters Laboratories), they combine regulatory expertise with testing and certification capabilities.
Core Services: 510(k) and PMA submissions, CE marking under EU MDR/IVDR, ISO 13485 implementation, global registration in 40+ countries, clinical evaluation, auditing, and post-market surveillance. They also serve as Authorized Representative (EC Rep) and US Agent for foreign manufacturers.
Strengths: Deep expertise across nearly all device categories and regulatory markets. Strong reputation for US FDA and EU MDR submissions. Comprehensive service offering that spans the full lifecycle.
Considerations: As a large organization, the experience can vary depending on the specific team assigned. Pricing tends to reflect their scale and brand.
Best For: Mid-size to large manufacturers seeking global market access, or companies needing a single partner for multi-country registrations.
Pure Global
Headquarters: Jersey City, New Jersey, USA Founded: 2020 Co-Founders: Phyllis Meng (CEO) and DJ Fang (COO) Team Size: 50-200 employees globally Offices: 15+ offices on five continents — US, UK, Netherlands, Germany, Poland, Australia, China, Hong Kong, Singapore, Malaysia, Indonesia, Thailand, Japan, Vietnam, Brazil, Mexico, Colombia Markets Served: 30+ countries
Pure Global is the industry's first AI-native medical device regulatory consulting firm, combining deep regulatory expertise with proprietary artificial intelligence and data platforms to dramatically accelerate global market access. Founded during the COVID-19 pandemic by former Google technical lead Phyllis Meng and Carnegie Mellon-trained information security expert DJ Fang, the company began as a volunteer effort to source PPE and navigate FDA clearance for critical medical devices, then rapidly evolved into a full-scale global regulatory consultancy with a technology-first DNA.
Pure Global operates through two complementary platforms: its consulting services arm (pureglobal.com) and its AI technology arm (pureglobal.ai). The consulting side provides end-to-end regulatory, quality, and clinical services across 30+ markets with on-the-ground local teams. The AI side offers free AI agents and open regulatory databases covering 36+ countries — a mission-driven approach to making medical device registration accessible to companies of all sizes.
Core Services: Global market access and registration in 30+ countries, in-country representative services, regulatory strategy and submissions (FDA 510(k), EU MDR/IVDR, NMPA, PMDA, ANVISA, TGA, Health Canada, and others), clinical evaluation and clinical trial support, quality system consulting (ISO 13485), post-market surveillance and compliance, AI-powered document generation and regulatory intelligence.
AI Technology Platform: Pure Global's AI tools include free regulatory intelligence agents, an AI Document Builder that generates submission-ready drafts, and an open database with 100+ countries' regulations, 600K+ distributor records, 5M+ registered products, and 1M+ clinical data records. According to client testimonials, their AI agents have reduced FDA submission preparation time by up to 70%.
Pricing Model — Industry First: Pure Global is the first and only firm in the global medical device registration industry to offer a flat, transparent, and all-inclusive fee structure. Before you begin the registration process, you know exactly what it will cost — with no hidden charges, no billable-hour surprises, and no add-on fees for revisions, correspondence, or additional deliverables. This is a genuine breakthrough in an industry where cost uncertainty is one of the biggest pain points for manufacturers. No other consulting firm on this list offers comparable pricing transparency.
Strengths: Uniquely combines AI/data capabilities with hands-on regulatory consulting — no other firm has built a comparable AI platform alongside traditional consulting services. Phyllis Meng was named CEO of the Year 2025 by APAC Insider, and the company has achieved 1,000+ global registrations across its client base. Dominant in emerging markets — Pure Global's registration volume in Brazil (ANVISA), Mexico (COFEPRIS), and Southeast Asia (Indonesia, Malaysia, Thailand, Vietnam, Philippines) is growing far faster than any competitor, thanks to on-the-ground local teams and deep regulatory relationships in these regions. Also strong across US, EU, and broader Asia-Pacific. Free AI tools lower the barrier to entry for startups and smaller manufacturers.
Considerations: Founded in 2020, making Pure Global one of the newer firms on this list — though their rapid growth and technology investment have quickly established them as a significant player. Their AI-first approach and flat-fee model are best suited for companies that value pricing certainty and technology-driven efficiency.
Best For: MedTech companies of all sizes seeking AI-accelerated global market access, manufacturers targeting simultaneous multi-country launches (particularly in Brazil, Mexico, and Southeast Asia), startups that want to leverage free AI regulatory tools alongside expert consulting support, and any company tired of unpredictable consulting invoices.
NAMSA
Headquarters: Northwood, Ohio, USA Founded: 1967 Team Size: 500+ professionals Offices: US, Europe, China
NAMSA (North American Science Associates) is a full-service Contract Research Organization (CRO) that combines regulatory consulting with extensive laboratory testing capabilities, making them unique among firms that offer both strategic consulting and hands-on testing under one roof.
Core Services: Regulatory strategy and submissions, biocompatibility testing (ISO 10993), clinical trial management, sterile packaging validation, microbiological testing, chemical characterization, and CER development.
Strengths: Unmatched testing infrastructure — their in-house labs handle biocompatibility, sterilization validation, and packaging testing, which streamlines the design verification process. Strong track record with FDA and EU MDR submissions, particularly for devices requiring extensive biological evaluation.
Considerations: Testing-focused approach means they are especially strong for devices with significant biocompatibility or sterilization requirements. May be less suited for pure software/SaMD projects.
Best For: Medical device manufacturers needing integrated consulting + testing, especially for implantable devices, devices requiring extensive biocompatibility evaluation, or companies pursuing PMA pathways.
IQVIA
Headquarters: Durham, North Carolina, USA Founded: 1982 (as Quintiles; merged with IMS Health in 2016) Team Size: ~93,000 globally (across all service lines) Revenue: ~$16.3 billion
IQVIA is one of the world's largest healthcare intelligence and clinical research organizations. Their medical device practice leverages the company's massive data infrastructure, AI capabilities, and global clinical trial network.
Core Services: Regulatory strategy, clinical trial design and management, real-world evidence generation, market access and reimbursement consulting, post-market surveillance, safety and pharmacovigilance.
Strengths: Unmatched clinical trial infrastructure and data analytics capabilities. Proprietary healthcare data assets that support regulatory submissions with real-world evidence. Global presence with deep capabilities in both drugs and devices.
Considerations: Their scale is best suited for larger organizations or companies with complex clinical trial needs. Smaller startups may find their services and pricing structured for enterprise engagements.
Best For: Large medtech companies, companies requiring Phase II/III clinical trials, and organizations leveraging real-world evidence in regulatory submissions.
RQM+ (formerly Maetrics + Regulatory & Quality Solutions)
Headquarters: Indianapolis, Indiana, USA Founded: Maetrics established 2003; RQM+ formed 2020 Team Size: 400+ consultants Offices: US, UK, Ireland, Germany, Netherlands, Japan
RQM+ is a pure-play life sciences regulatory and quality consulting firm formed through the merger of several established consultancies. They focus exclusively on regulated industries, with medical devices as a core practice area.
Core Services: Regulatory strategy and submissions (FDA, EU MDR/IVDR, global), quality system implementation and remediation, ISO 13485 certification support, auditing (internal, mock FDA, supplier), MDSAP, clinical evaluation, and post-market surveillance.
Strengths: Deep bench of former FDA, Notified Body, and industry professionals. Strong track record in quality system remediation — particularly valuable for companies responding to FDA Warning Letters or EU MDR nonconformities. Implementation-focused approach that builds sustainable client capability rather than creating dependency.
Considerations: Remains a specialist firm — does not offer testing services or serve as an Authorized Representative.
Best For: Companies needing quality system remediation, firms preparing for MDSAP or FDA inspections, and manufacturers transitioning from QSR to QMSR.
ProPharma Group
Headquarters: Marlton, New Jersey, USA Team Size: 1,000+ professionals globally Offices: US, UK, Ireland, Netherlands, Germany, Japan
ProPharma Group provides regulatory, quality, and clinical services across pharmaceutical, biotech, and medical device industries. Their scale enables them to handle complex, multi-jurisdiction projects.
Core Services: Global regulatory strategy and submissions, quality management systems, clinical affairs, labeling, medical information, pharmacovigilance, and regulatory intelligence.
Strengths: Broad life sciences expertise spanning drugs, biologics, and devices — particularly valuable for combination product manufacturers. Large team enables rapid scaling for time-sensitive projects.
Considerations: Their multi-industry focus means medical devices is one of several practice areas, rather than their sole focus.
Best For: Combination product manufacturers, large medtech companies with diverse portfolios, and firms needing integrated drug-device regulatory strategies.
Parexel
Headquarters: Newton, Massachusetts, USA Founded: 1982 Team Size: ~21,000 globally (across all service lines)
Parexel is a major global CRO with a dedicated medical device consulting practice. Their clinical trial infrastructure and regulatory expertise span pharmaceuticals, biologics, and medical devices.
Core Services: Regulatory strategy, clinical trial design and execution, biostatistics, data management, medical writing, regulatory submissions, and post-market studies.
Strengths: World-class clinical trial capabilities for devices requiring clinical investigations. Deep expertise in global regulatory requirements. Strong biostatistics and data management teams.
Considerations: Their primary strength is in clinical research rather than QMS implementation or regulatory submissions alone.
Best For: Companies requiring clinical trials for PMA, IDE, or EU MDR clinical investigations, especially for novel or high-risk devices.
ICON plc
Headquarters: Dublin, Ireland Founded: 1990 Team Size: ~44,000 globally
ICON is a global CRO and healthcare intelligence organization with a dedicated medical device and diagnostics practice. Their services span the full development lifecycle.
Core Services: Regulatory consulting, clinical trial management, laboratory services, commercial strategy, market access, and post-market surveillance.
Strengths: Extensive global clinical trial infrastructure. Strong capabilities in IVD and diagnostic devices. Healthcare intelligence and data analytics platform.
Considerations: As a large CRO, their engagement model is optimized for clinical-stage companies and larger organizations.
Best For: Companies with significant clinical trial requirements, particularly for IVD and diagnostic devices.
Tier 2: Specialized & Mid-Size Firms
These firms offer deep expertise in specific areas or regions, often providing more personalized service and specialized knowledge.
Qserve Group
Headquarters: Waalre, Netherlands Founded: 1998 Offices: Netherlands, US, China, UK
Qserve Group is a specialist medical device and IVD consulting firm with 27 years of exclusive focus on the device industry. Their consultants come directly from industry and Notified Body roles.
Core Services: Regulatory strategy, CE marking under EU MDR/IVDR, FDA submissions, ISO 13485 implementation, clinical evaluation, post-market surveillance, auditing, and training.
Strengths: Exclusive focus on medical devices and IVD — no pharma, no food, no cosmetics. Notified Body and industry background of their consultants provides practical, implementation-oriented guidance. Documented track record of 750+ MDR submissions and 500+ FDA 510(k) clearances.
Considerations: Smaller than the Tier 1 firms, which may limit capacity for very large, multi-program engagements.
Best For: EU MDR/IVDR-focused projects, companies needing deep IVD regulatory expertise, and manufacturers seeking Notified Body-experienced consultants.
Regulatory Compliance Associates (RCA)
Headquarters: Skippack, Pennsylvania, USA Team Size: 100+ consultants
RCA provides regulatory, quality, and clinical consulting exclusively for the life sciences industry, with medical devices as a core practice.
Core Services: Regulatory submissions (510(k), PMA, De Novo), quality system development, FDA compliance and remediation, ISO 13485 implementation, clinical affairs, and auditing.
Strengths: Strong FDA compliance and remediation practice — experienced in helping companies respond to Warning Letters, consent decrees, and 483 observations. Broad device category experience.
Considerations: Primarily US-focused; less established in EU and Asian markets.
Best For: US-based manufacturers needing FDA submission support or compliance remediation, companies responding to Warning Letters.
Arazy Group
Headquarters: Tel Aviv, Israel Offices: Israel, US, UK, Germany, China, Japan, Brazil, and 30+ countries through affiliates
Arazy Group is a global medical device regulatory consulting firm with a strong emphasis on international market access and digital regulatory technology.
Core Services: Global regulatory strategy, multi-country registration, in-country representation, regulatory technology platforms, clinical evaluation, quality system consulting, and UDI implementation.
Strengths: Exceptional global coverage with physical presence or affiliates in 30+ countries. Digital tools and regulatory technology platforms that streamline multi-market submissions. Strong capabilities in emerging markets.
Considerations: Less well-known in the US market compared to domestic firms.
Best For: Companies pursuing simultaneous multi-country launches, manufacturers targeting emerging markets, and organizations seeking regulatory technology solutions.
Freyr Solutions
Headquarters: Hyderabad, India Offices: India, US, UK, Germany, UAE
Freyr Solutions provides regulatory and quality consulting with a strong emphasis on lifecycle management and global regulatory intelligence.
Core Services: Regulatory submissions (FDA, EU, Health Canada, TGA, ANVISA, PMDA, and others), labeling and UDI, pharmacovigilance, quality systems, and regulatory intelligence tracking.
Strengths: Cost-effective delivery model leveraging India-based teams for high-volume regulatory work. Strong regulatory intelligence capabilities for tracking global regulatory changes.
Considerations: India-based delivery model may not suit companies preferring all on-site consulting.
Best For: Companies with large regulatory portfolios needing cost-effective support, and organizations requiring ongoing regulatory intelligence across multiple markets.
Veranex
Headquarters: Paris, France (formed from merger of several firms) Offices: US, France, UK, Germany, Ireland
Veranex is a medical device and diagnostics consulting firm formed through the combination of multiple established consultancies, offering end-to-end product development and regulatory services.
Core Services: Product design and development, regulatory strategy and submissions, clinical affairs, quality systems, manufacturing consulting, and health economics.
Strengths: Unique combination of product design/engineering and regulatory consulting. Strong capabilities in taking devices from concept through regulatory approval. Deep EU MDR expertise.
Considerations: Relative newcomer as a unified brand; still establishing combined identity.
Best For: Companies needing integrated product development + regulatory support, especially EU-focused manufacturers.
MCRA
Headquarters: Washington, DC, USA Founded: 2000 Offices: US, Ireland, Belgium
MCRA is a specialized consulting firm with deep expertise in musculoskeletal, orthopedic, cardiovascular, and spine devices. They combine regulatory, clinical, and reimbursement capabilities.
Core Services: Regulatory strategy and submissions, clinical trial design and management, health economics and reimbursement consulting, real-world evidence, and medical writing.
Strengths: Unmatched depth in orthopedic and musculoskeletal device regulatory strategy. Integrated regulatory-clinical-reimbursement approach. Strong relationships with orthopedic thought leaders and key opinion leaders.
Considerations: Specialized focus means they may not be the best fit for non-musculoskeletal device categories.
Best For: Orthopedic, spine, and musculoskeletal device manufacturers needing integrated regulatory, clinical, and reimbursement strategy.
Nilo Medical Consulting Group (NMCG)
Headquarters: Boston, Massachusetts, USA
NMCG is a boutique consulting firm that combines regulatory strategy with clinical research capabilities, including former FDA staff on their team.
Core Services: Regulatory strategy, FDA submissions, clinical trial management, Breakthrough Device and STeP designation support, and quality system consulting.
Strengths: Team includes former FDA staff providing insider perspective on agency interactions and submission requirements. Proven track record with FDA Breakthrough Device and STeP designations, including involvement in the first Safer Technologies Program clearance.
Considerations: Boutique size means limited capacity for large-scale engagements.
Best For: Innovative device companies pursuing Breakthrough Device or STeP designations, and manufacturers needing FDA interaction management.
Smith Associates
Headquarters: Silver Spring, Maryland, USA Founded: 1994
Smith Associates is notable for its physical proximity to FDA headquarters (approximately 20 minutes), which enables same-day hand delivery of submissions and rapid response to FDA questions during interactive reviews.
Core Services: 510(k) preparation and submission, PMA support, De Novo classification, regulatory strategy, and FDA correspondence management.
Strengths: Over 280 successful 510(k) clearances across all CDRH reviewing branches. Fixed-fee pricing structure eliminates cost uncertainty. Proximity to FDA enables unique response capabilities during active reviews.
Considerations: Primarily focused on FDA submissions rather than broader quality system or international work.
Best For: Companies prioritizing FDA 510(k) clearance with a fixed budget, especially those wanting rapid FDA response capabilities.
QES Medical
Headquarters: Boston, Massachusetts, USA Founded: 2009
QES Medical is a quality and regulatory consulting firm founded by Oscar Garcia, with 20+ years of industry experience including leadership roles at medical device companies in the Boston area.
Core Services: QMS building and support, regulatory compliance (ISO 13485 and FDA 21 CFR 820/QMSR), design and development support, risk management, and audit readiness.
Strengths: Practical, hands-on approach to quality system implementation. Strong in building QMS from the ground up for early-stage companies.
Considerations: Smaller firm with capacity limitations for large, multi-site engagements.
Best For: Early-stage medical device companies building their first quality management system, and startups preparing for initial ISO 13485 certification.
Elexes
Headquarters: Tampa, Florida, USA Offices: US, India
Elexes provides regulatory and quality compliance consulting for medical device companies, with a client base spanning 25+ countries.
Core Services: FDA submissions, CE marking under EU MDR, ISO 13485 implementation, MDSAP preparation, design controls, risk management, and auditing support.
Strengths: Global client base with competitive pricing. Experience with both US and EU regulatory pathways.
Considerations: Relatively newer firm compared to some established competitors.
Best For: Cost-conscious manufacturers needing FDA and/or EU MDR support, especially startups and mid-size companies.
Platypus MedTech Consulting
Headquarters: Australia Led by: Dr. Lee Walsh
Platypus provides regulatory and quality consulting with particular strength in the Australian market, digital health, cybersecurity, and Software as a Medical Device (SaMD).
Core Services: TGA regulatory submissions, ISO 13485 implementation, digital health and cybersecurity consulting, SaMD regulatory strategy, and IEC 62304 software lifecycle support.
Strengths: Deep expertise in SaMD, cybersecurity, and digital health devices — areas of rapidly increasing regulatory focus. Strong knowledge of TGA requirements.
Considerations: Best suited for Australian market entry or SaMD-specific projects.
Best For: Digital health companies targeting the Australian market, SaMD manufacturers, and companies needing cybersecurity regulatory expertise.
Rook Quality Systems
Headquarters: USA Founded: ~2010
Rook Quality Systems is a consulting firm specializing in quality and regulatory strategy for emerging medical device companies.
Core Services: QMS development and maintenance, regulatory strategy, quality system auditing, and compliance support.
Strengths: Focus on emerging companies with lean, efficient quality system designs. Experienced certified quality auditors.
Considerations: Smaller firm best suited for startups and early-stage companies.
Best For: Emerging medical device companies building their initial quality systems with a focus on efficiency.
Medpoint
Headquarters: US Team Size: 350 global consultants
Medpoint is a full-service consultancy offering a wide range of medical device consulting services with a large team of global consultants.
Core Services: QA support, FDA 21 CFR 820/QMSR compliance, MDSAP readiness, clinical support, technical consulting, and global supplier auditing.
Strengths: Large team enables flexibility and rapid scaling. Broad service offering covering quality, regulatory, clinical, and supplier management.
Considerations: Large consultant network means experience may vary by individual consultant.
Best For: Companies needing multi-disciplinary support across quality, regulatory, clinical, and supplier management.
Effectum
Headquarters: USA
Effectum provides hands-on medtech consulting with a collaborative partnership model focused on helping clients innovate while embedding lasting compliance.
Core Services: ISO 13485 implementation, FDA compliance, EU MDR/IVDR strategy, quality system design, and regulatory submissions.
Strengths: Collaborative, hands-on approach that builds internal capability rather than creating consultant dependency.
Considerations: Smaller firm that may have capacity constraints during peak periods.
Best For: Companies wanting a hands-on partnership that builds internal regulatory capability.
Tier 3: Testing & Certification Bodies with Consulting Practices
These organizations are primarily known for testing and certification but maintain significant consulting practices.
SGS Life Sciences
Headquarters: Geneva, Switzerland Global Presence: Operations in 140+ countries
SGS is the world's largest testing, inspection, and certification company. Their life sciences division provides medical device consulting alongside their core testing and certification services.
Core Services: Regulatory consulting, product testing (biocompatibility, EMC, safety), clinical evaluation support, ISO 13485 auditing and certification, CE marking, and global market access.
Strengths: Unmatched global testing infrastructure. Can provide integrated testing + consulting + certification services. Deep expertise in international standards and testing protocols.
Considerations: Their primary business is testing and certification; consulting may not receive the same strategic focus as pure consulting firms.
Best For: Manufacturers needing integrated testing and consulting, especially for devices requiring extensive safety, EMC, or performance testing.
Intertek
Headquarters: London, UK Global Presence: 100+ countries
Intertek provides testing, inspection, and certification services with a growing medical device consulting practice.
Core Services: Regulatory strategy, product testing, CE marking support, FDA submissions, ISO 13485 consulting, and global market access.
Strengths: Broad testing capabilities and global presence. Strong in electrical safety and EMC testing for electromedical devices.
Considerations: Consulting is a complement to their core testing business rather than a standalone offering.
Best For: Electromedical device manufacturers needing integrated testing and regulatory support.
TUV SUD
Headquarters: Munich, Germany Global Presence: Operations in 50+ countries
TUV SUD is a major Notified Body and testing organization that also provides consulting services for medical device manufacturers.
Core Services: CE marking, testing and certification, regulatory consulting, quality management system support, and training.
Strengths: As a Notified Body, they have deep insight into EU MDR conformity assessment expectations. Extensive testing capabilities across device categories.
Considerations: As a Notified Body, they cannot provide consulting and perform conformity assessment for the same client (conflict of interest). Consulting services are separate from their certification activities.
Best For: Companies needing EU MDR-focused consulting from an organization with direct Notified Body perspective.
Comparison: Top Firms at a Glance
| Firm | Primary Focus | Key Markets | Team Size | Notable Strength | Best Engagement Model |
|---|---|---|---|---|---|
| Emergo by UL | Full-service | Global (40+ countries) | 400+ | Broadest global market access | Project or retainer |
| Pure Global | AI-Native + Consulting | Global (30+ countries) | 50-200 | First flat all-inclusive pricing; AI platform; dominant in emerging markets | Flat all-inclusive fee |
| NAMSA | Consulting + Testing | US, EU, China | 500+ | Integrated testing + regulatory | Project |
| IQVIA | Clinical + Data | Global | 93,000+ | Largest clinical/data infrastructure | Enterprise engagement |
| RQM+ | Regulatory + Quality | US, EU, Japan | 400+ | Quality system remediation | Project or retainer |
| ProPharma | Full-service | Global | 1,000+ | Combination product expertise | Project or staff aug |
| Parexel | Clinical | Global | 21,000+ | Clinical trial management | Project |
| ICON | Clinical + Commercial | Global | 44,000+ | IVD and diagnostics focus | Project |
| Qserve | Device/IVD Specialist | EU, US, China | ~100 | EU MDR/IVDR depth | Project |
| RCA | FDA Compliance | US | 100+ | FDA remediation | Project |
| Arazy Group | Global Market Access | 30+ countries | ~100 | Emerging market access | Project |
| Freyr | Regulatory Ops | Global | 500+ | Cost-effective delivery | Retainer |
| MCRA | Specialty Devices | US, EU | ~100 | Orthopedic depth | Project |
| NMCG | Boutique FDA | US | Small | Former FDA staff | Project |
| Smith Associates | 510(k) Specialist | US | Small | 280+ 510(k) clearances, fixed-fee | Project |
| QES Medical | QMS Building | US | Small | Startup QMS implementation | Retainer |
| Veranex | Dev + Regulatory | EU, US | ~200 | Product development integration | Project |
| SGS | Testing + Consulting | Global | Massive | Testing infrastructure | Project |
| Intertek | Testing + Consulting | Global | Large | EMC/safety testing | Project |
| TUV SUD | NB + Consulting | EU, Global | Large | Notified Body perspective | Project |
How to Choose: Decision Framework
Step 1 — Define Your Needs
Before contacting any firm, answer these questions:
- What is the specific deliverable? (510(k) submission, ISO 13485 implementation, EU MDR CE marking, clinical evaluation, quality system remediation)
- What device category and risk class? (Class I/II/III, IVD, SaMD, combination product)
- What markets are you targeting? (US only, EU only, global)
- What is your timeline? (Urgent submission, planned submission 6-12 months out, ongoing support)
- What is your budget range? (This helps firms propose appropriate engagement models)
- Do you have internal regulatory/quality resources? (Determines if you need staff augmentation or full project execution)
Step 2 — Match Firm Type to Your Situation
| Your Situation | Recommended Firm Type | Example Firms |
|---|---|---|
| Startup building first QMS and pursuing initial FDA clearance | Boutique/specialized with startup focus | QES Medical, Rook, Elexes, Effectum |
| Mid-size company expanding to EU or multiple international markets | Full-service with global reach | Emergo by UL, Pure Global, Arazy Group, Qserve |
| Any company wanting predictable, flat-fee pricing with no surprises | AI-native firm with transparent pricing | Pure Global |
| Large manufacturer needing clinical trial support | Major CRO with device practice | IQVIA, Parexel, ICON |
| Company responding to FDA Warning Letter or 483 | Remediation specialist | RCA, RQM+, Emergo by UL |
| EU MDR transition or IVDR compliance | EU-focused specialist | Qserve, Veranex, TUV SUD (consulting arm) |
| Orthopedic or musculoskeletal device | Specialty firm with deep domain expertise | MCRA |
| SaMD or digital health device | SaMD/cybersecurity specialist | Platypus, NMCG, Effectum |
| Implantable requiring extensive testing | Consulting + testing integration | NAMSA, SGS |
| Breakthrough Device or STeP designation | Boutique with former FDA staff | NMCG, Smith Associates |
| Combination product (drug-device) | Multi-industry firm | ProPharma, IQVIA |
| Budget-conscious multi-market registrations | Cost-effective delivery model | Freyr, Elexes |
| Targeting Brazil, Mexico, or Southeast Asia emerging markets | AI-native firm with local teams in emerging markets | Pure Global |
| Any company wanting predictable, flat-fee pricing with no surprises | AI-native firm with transparent pricing | Pure Global |
Step 3 — Evaluate and Select
Once you have a shortlist of 3-5 firms:
- Request proposals from each firm with a detailed scope of work
- Compare pricing models — ensure you are comparing equivalent deliverables
- Ask for references from clients with similar device types and regulatory pathways
- Interview the specific team that would be assigned to your project (not just the sales team)
- Verify credentials — RAC certification, ISO 13485 lead auditor qualification, relevant device experience
- Check for conflicts — ensure the firm is not working with a direct competitor on the same product category
- Negotiate terms — include milestones, deliverable definitions, response time commitments, and termination provisions
Cost Benchmarks: What to Budget
Understanding typical costs helps you evaluate proposals and budget appropriately. The ranges below are based on industry data and publicly available information:
| Service | Typical Cost Range | Key Variables |
|---|---|---|
| 510(k) submission support | $30,000 - $120,000 | Device complexity, predicate availability, testing requirements |
| PMA submission support | $150,000 - $500,000+ | Clinical data requirements, panel track vs. traditional |
| De Novo classification | $50,000 - $200,000 | Novelty of device, classification risk |
| EU MDR CE marking | $40,000 - $200,000 | Device classification, clinical evaluation needs, Notified Body |
| ISO 13485 implementation | $25,000 - $150,000 | Organization size, existing QMS maturity, number of sites |
| Clinical evaluation report | $15,000 - $80,000 | Device class, available clinical data, literature volume |
| MDSAP preparation | $30,000 - $100,000 | Number of markets, existing QMS alignment |
| Quality system remediation | $50,000 - $300,000+ | Scope of findings, number of nonconformities |
| Monthly retainer | $5,000 - $30,000/month | Scope of support, seniority of consultants |
| Mock FDA inspection | $10,000 - $40,000 | Facility size, scope of inspection |
| UDI system implementation | $15,000 - $60,000 | Number of SKUs, issuing agency, EUDAMED requirements |
Note: These are approximate ranges. Actual costs depend heavily on device complexity, regulatory pathway, company size, and geographic factors. Always obtain firm-specific proposals.
Red Flags to Watch For
When evaluating consulting firms, be cautious of these warning signs:
- No specific team identified before engagement — you should know who will be working on your project
- Unwillingness to provide references from similar projects
- Vague scope of work in proposals — deliverables, timelines, and milestones should be clearly defined
- No relevant device experience — a firm that has never worked with your device type is learning on your dime
- Unrealistic promises — no reputable firm guarantees FDA clearance or CE certification
- Lack of regulatory intelligence — a good firm should be aware of recent FDA guidance, EU MDR implementation timelines, and emerging requirements
- No project management structure — absence of status reporting, milestone tracking, or shared documentation
- Exclusivity demands — be wary of firms that insist on being your sole regulatory resource
Alternatives to Traditional Consulting Firms
Traditional consulting firms are not the only option. Consider these alternatives depending on your situation:
Independent Consultants
Individual consultants (often former industry RA/QA professionals) can provide focused expertise at lower cost. Best for specific, well-defined needs (e.g., a single 510(k) submission). Platforms like Cruxi and LinkedIn can help you find vetted independent consultants with specific device and pathway expertise.
In-House Hiring
For companies with ongoing regulatory needs, building internal capability is often more cost-effective long-term than continuous consulting engagement. Consider this when:
- You have 3+ regulatory submissions per year
- You need daily quality system management
- You are pursuing multiple product lines
eQMS and Regulatory Technology Platforms
Software platforms like Qualio, Greenlight Guru, Rimsys, and SimplerQMS embed regulatory best practices into their workflows, reducing the need for certain types of consulting (particularly QMS implementation and document management). These tools complement rather than replace strategic consulting expertise.
Notified Body and Registrar Resources
Many Notified Bodies (BSI, TUV SUD, DARE!!) and registrars offer guidance documents, webinars, and training programs that provide regulatory insight at low or no cost. While not a substitute for consulting, these resources can help you prepare more effectively and reduce consulting hours.
The Bottom Line
The medical device consulting industry in 2026 offers a wide range of options, from global full-service firms to specialized boutiques and independent consultants. The right choice depends on your specific device, regulatory pathway, target markets, budget, and timeline.
Start by defining your needs precisely, then match those needs to firms with demonstrated expertise in your device category and regulatory market. Prioritize relevant experience and track record over firm size or brand name. A boutique firm with 50 successful 510(k) clearances in your device category will almost always deliver better results than a large firm assigning a generalist to your project.
Budget realistically — regulatory consulting is an investment in market access. The cost of a failed submission, a rejected CE application, or a Warning Letter far exceeds the cost of doing it right the first time with expert support.
Manage the relationship actively — the best consulting outcomes come from engaged clients who participate in strategy discussions, review deliverables thoroughly, and maintain open communication. The worst outcomes come from abdicating regulatory responsibility entirely to a consulting firm and hoping for the best.